Most Read Articles
12 Jun 2018
Percutaneous coronary intervention (PCI) is a safe procedure to perform on obese and morbidly obese patients, a recent study has shown.
Pank Jit Sin, 07 Jun 2018
A reduction as small as 2 mm Hg can lower cardiovascular risks among patients with cardiovascular disease (CVD), says an expert.
01 Mar 2016
Teaching healthcare providers to execute a chest compression (CC) of 6-7 cm depth may enhance quality CC depth in patients on a mattress during cardiopulmonary resuscitation (CPR) in the hospital, based on a prospective, randomised, controlled study.
06 Jun 2018
Increased concentrations of omega-3 fatty acid (n-3 FA) appear to contribute to a clinically relevant reduction in blood pressure (BP) levels among normotensive young and healthy individuals, as shown by the results of a recent cross-sectional study.

New data show promise for renal denervation in hypertension

12 Jun 2018

Renal denervation provides meaningful reductions in systolic blood pressure (BP) in hypertensive patients on or off BP-lowering medications, results of the SPYRAL HTN-ON MED and RADIANCE-HTN SOLO trials have shown.

In SPYRAL HTN-ON MED, 467 patients with uncontrolled hypertension despite the use of up to three antihypertensive medications were randomized to undergo renal denervation or a sham control procedure. Results from the first 80 patients showed significantly greater reductions in the renal denervation vs sham control group in office systolic BP (difference, -6.8 mm Hg; p=0.05), 24-hour systolic BP (difference, -7.4 mm Hg; p=0.0051), office diastolic BP (difference, -3.5 mm Hg; p=0.0478) and 24-hour diastolic BP (difference, -4.1 mm Hg, p=0.0292) at 6 months. [Lancet 2018, doi: https://doi.org/10.1016/S0140-6736(18)30951-6]

In RADIANCE-HTN SOLO, 146 patients with hypertension after discontinuation of up to two antihypertensive medications were randomized to undergo renal denervation or a sham procedure. At 2 months, patients in the renal denervation group had greater reductions in daytime ambulatory systolic BP than those in the sham control group (difference, -6.3 mm Hg; p=0.0001). [Lancet 2018, doi: https://doi.org/10.1016/S0140-6736(18)31082-1]

The two trials enrolled different patient populations. In SPYRAL HTN-ON MED, eligible patients had an office systolic BP of 150–180 mm Hg and a diastolic BP of 90 mm Hg, a 24-hour ambulatory systolic BP of 140–170 mm Hg at second screening, and were on 1–3 antihypertensive medications at stable doses for at least 6 weeks. In contrast, RADIANCE-HTN SOLO enrolled patients with ambulatory BP of 135/85 mm Hg and <170/105 mm Hg after a 4-week discontinuation of 2 antihypertensive medications.

No major adverse events were reported for either procedure in both trials. In SPYRAL HTN-ON MED, adherence to antihypertensive medications was incomplete, at about 60 percent, and varied for individual patients throughout the trial.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
12 Jun 2018
Percutaneous coronary intervention (PCI) is a safe procedure to perform on obese and morbidly obese patients, a recent study has shown.
Pank Jit Sin, 07 Jun 2018
A reduction as small as 2 mm Hg can lower cardiovascular risks among patients with cardiovascular disease (CVD), says an expert.
01 Mar 2016
Teaching healthcare providers to execute a chest compression (CC) of 6-7 cm depth may enhance quality CC depth in patients on a mattress during cardiopulmonary resuscitation (CPR) in the hospital, based on a prospective, randomised, controlled study.
06 Jun 2018
Increased concentrations of omega-3 fatty acid (n-3 FA) appear to contribute to a clinically relevant reduction in blood pressure (BP) levels among normotensive young and healthy individuals, as shown by the results of a recent cross-sectional study.